Zealand Pharma A/S (ZLDPY)
OTCMKTS · Delayed Price · Currency is USD
10.00
-2.86 (-22.24%)
At close: Aug 1, 2025

Zealand Pharma Statistics

Total Valuation

Zealand Pharma has a market cap or net worth of 4.96 billion. The enterprise value is 2.42 billion.

Market Cap4.96B
Enterprise Value 2.42B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date Aug 14, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +18.37%
Shares Change (QoQ) +1.58%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 59.90M

Valuation Ratios

The trailing PE ratio is 4.72.

PE Ratio 4.72
Forward PE n/a
PS Ratio 3.46
PB Ratio 2.02
P/TBV Ratio 2.02
P/FCF Ratio 4.19
P/OCF Ratio 4.18
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.14, with an EV/FCF ratio of 2.04.

EV / Earnings 2.30
EV / Sales 1.70
EV / EBITDA 2.14
EV / EBIT 2.15
EV / FCF 2.04

Financial Position

The company has a current ratio of 15.09, with a Debt / Equity ratio of 0.03.

Current Ratio 15.09
Quick Ratio 15.08
Debt / Equity 0.03
Debt / EBITDA 0.06
Debt / FCF 0.05
Interest Coverage 224.24

Financial Efficiency

Return on equity (ROE) is 53.44% and return on invested capital (ROIC) is 34.83%.

Return on Equity (ROE) 53.44%
Return on Assets (ROA) 32.86%
Return on Invested Capital (ROIC) 34.83%
Return on Capital Employed (ROCE) 44.76%
Revenue Per Employee 3.38M
Profits Per Employee 2.48M
Employee Count335
Asset Turnover 0.67
Inventory Turnover n/a

Taxes

In the past 12 months, Zealand Pharma has paid 84.07 million in taxes.

Income Tax 84.07M
Effective Tax Rate 7.40%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 18.89
Average Volume (20 Days) 235

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Zealand Pharma had revenue of 1.43 billion and earned 1.05 billion in profits. Earnings per share was 14.75.

Revenue1.43B
Gross Profit 1.44B
Operating Income 1.13B
Pretax Income 1.14B
Net Income 1.05B
EBITDA 1.13B
EBIT 1.13B
Earnings Per Share (EPS) 14.75
Full Income Statement

Balance Sheet

The company has 2.61 billion in cash and 62.49 million in debt, giving a net cash position of 2.55 billion.

Cash & Cash Equivalents 2.61B
Total Debt 62.49M
Net Cash 2.55B
Net Cash Per Share n/a
Equity (Book Value) 2.46B
Book Value Per Share 34.91
Working Capital 2.50B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.19 billion and capital expenditures -2.25 million, giving a free cash flow of 1.19 billion.

Operating Cash Flow 1.19B
Capital Expenditures -2.25M
Free Cash Flow 1.19B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 100.06%, with operating and profit margins of 78.88% and 73.34%.

Gross Margin 100.06%
Operating Margin 78.88%
Pretax Margin 79.20%
Profit Margin 73.34%
EBITDA Margin 78.98%
EBIT Margin 78.88%
FCF Margin 82.64%

Dividends & Yields

Zealand Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -18.37%
Shareholder Yield n/a
Earnings Yield 21.20%
FCF Yield 23.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Zealand Pharma has an Altman Z-Score of 21.97 and a Piotroski F-Score of 6.

Altman Z-Score 21.97
Piotroski F-Score 6